首页 | 本学科首页   官方微博 | 高级检索  
检索        

云克联合治疗强直性脊柱炎疗效评价
引用本文:王翠香,张立民.云克联合治疗强直性脊柱炎疗效评价[J].泰山医学院学报,2007,28(8):640-642.
作者姓名:王翠香  张立民
作者单位:泰山医学院附属泰安医院,山东,泰安,271000
摘    要:目的评价云克联合治疗强直性脊柱炎的疗效。方法选取活动期强直性脊柱炎初诊患者56例,随机分为两组:治疗组(云克 甲氨喋呤和/或柳氮磺吡啶)28例、对照组(非甾类抗炎药 甲氨喋呤和/或柳氮磺吡啶)28例,对比观察两组治疗前后临床症状、实验室指标变化及不良反应。结果治疗后两组各项指标均较治疗前明显改善(P<0.001),治疗组总有效率为95%,对照组总有效率93%,两组比较,无统计学意义(P>0.05),治疗组在疼痛程度、疾病活动度评价及Dougados指数等指标的改善值高于对照组(P<0.05),且不良反应的发生率少于对照组,两者差异有统计学意义(P<0.05)。结论云克联合治疗强直性脊柱炎疗效可靠,副作用少。

关 键 词:脊柱炎  强直性  云克
文章编号:1004-7115(2007)08-0640-03
收稿时间:2007-04-09
修稿时间:2007年4月9日

Clinical analysis of ankylosing spondylitis treated with Yunke
WANG Cui-xiang,Zhang Li-min.Clinical analysis of ankylosing spondylitis treated with Yunke[J].Journal of Taishan Medical College,2007,28(8):640-642.
Authors:WANG Cui-xiang  Zhang Li-min
Abstract:Objective: To analyze the therapeutic effect and safety of 99mTc-methylene diphosphonate(MDP) in the treatment of ankylosing spondylitis(AS).Methods: Fifty-six patients with AS were randomized into two groups.Patients in treatment group were treated with 99mTc-MDP,sulfasalazine and/or methotrexate and in the control group with NASIDs,sulfasalazine and/or methotrexate.Clinical manifestation,laboratory examination before and after treatment and side effect were observed.Results: The total effect of this treatment was 91%,and the effect of relieving clinical symptom was significant,especially the morning stiffness and limitation of articulation function.No adverse effect was observed.Conclution: The clinical effect of 99mTc-MDP is obvious,and it is safe and has no significant adverse reaction.
Keywords:spondylitis  ankylosing  Yunke
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号